This is the second in a series of four papers updating the European Cystic Fibrosis Society (ECFS) standards for the care of people with CF. This paper focuses on establishing and maintaining health. The guidance is produced using an evidence-based framework and with wide stakeholder engagement, including people from the CF community. Authors provided a narrative description of their topic and statements, which were more directive. These statements were reviewed by a Delphi exercise, achieving good levels of agreement from a wide group for all statements. This guidance reinforces the importance of a multi-disciplinary CF team, but also describes developing models of care including virtual consultations. The framework for health is reinforce...
AbstractSince the earliest days of cystic fibrosis (CF) treatment, patient data have been recorded a...
Developments in managing CF continue to drive dramatic improvements in survival. As newborn screenin...
Cystic Fibrosis (CF) is a life-limiting genetic condition in which daily therapies to maintain lung ...
Cystic fibrosis (CF) has entered the era of variant-specific therapy, tailored to the genetic varian...
Specialised CF care has led to a dramatic improvement in survival in CF: in the last four decades, w...
A significant increase in life expectancy in successive birth cohorts of people with cystic fibrosis...
AbstractA significant increase in life expectancy in successive birth cohorts of people with cystic ...
AbstractSpecialised CF care has led to a dramatic improvement in survival in CF: in the last four de...
This is the final version. Available on open access from SAGE Publications via the DOI in this recor...
OBJECTIVE: Cystic fibrosis (CF), caused by mutations in the CF transmembrane conductance regulator (...
Specialised CF care has led to a dramatic improvement in survival in CF: in the last four decades, w...
AbstractThe care and condition of people with cystic fibrosis (CF) in 34 European countries is repor...
AbstractBackgroundSeveral guidelines for cystic fibrosis (CF) caregivers exist, but information abou...
AbstractIn patients with cystic fibrosis (CF), clinical trials are of paramount importance. Here, th...
AbstractIn patients with cystic fibrosis (CF), early intervention and prevention of lung disease is ...
AbstractSince the earliest days of cystic fibrosis (CF) treatment, patient data have been recorded a...
Developments in managing CF continue to drive dramatic improvements in survival. As newborn screenin...
Cystic Fibrosis (CF) is a life-limiting genetic condition in which daily therapies to maintain lung ...
Cystic fibrosis (CF) has entered the era of variant-specific therapy, tailored to the genetic varian...
Specialised CF care has led to a dramatic improvement in survival in CF: in the last four decades, w...
A significant increase in life expectancy in successive birth cohorts of people with cystic fibrosis...
AbstractA significant increase in life expectancy in successive birth cohorts of people with cystic ...
AbstractSpecialised CF care has led to a dramatic improvement in survival in CF: in the last four de...
This is the final version. Available on open access from SAGE Publications via the DOI in this recor...
OBJECTIVE: Cystic fibrosis (CF), caused by mutations in the CF transmembrane conductance regulator (...
Specialised CF care has led to a dramatic improvement in survival in CF: in the last four decades, w...
AbstractThe care and condition of people with cystic fibrosis (CF) in 34 European countries is repor...
AbstractBackgroundSeveral guidelines for cystic fibrosis (CF) caregivers exist, but information abou...
AbstractIn patients with cystic fibrosis (CF), clinical trials are of paramount importance. Here, th...
AbstractIn patients with cystic fibrosis (CF), early intervention and prevention of lung disease is ...
AbstractSince the earliest days of cystic fibrosis (CF) treatment, patient data have been recorded a...
Developments in managing CF continue to drive dramatic improvements in survival. As newborn screenin...
Cystic Fibrosis (CF) is a life-limiting genetic condition in which daily therapies to maintain lung ...